SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001011443-01-500005
Filing Date
2001-06-01
Accepted
2001-06-01 00:00:00
Documents
1
Group Members
HBK INVESTMENTS L PHBK INVESTMENTS L.P.

Document Format Files

Seq Description Document Type Size
1 LYNX THERAPEUTICS, INC. SCH. 13G lynx13g.htm SC 13G 13649
  Complete submission text file 0001011443-01-500005.txt   15655
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45671 | Film No.: 1652875
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 300 CRESCENT CT STE 700 DALLAS TX 75201
Business Address 300 CRESCENT CT STE 700 DALLAS TX 75201
HBK INVESTMENTS L P (Filed by) CIK: 0001011443 (see all company filings)

IRS No.: 752622581 | State of Incorp.: DE | Fiscal Year End: 1231